SYNPO2 — Synaptopodin 2
Introduction
flowchart TD
SYNPO2["SYNPO2"] -->|"interacts with"| Als["Als"]
SYNPO2["SYNPO2"] -->|"interacts with"| Ms["Ms"]
SYNPO2["SYNPO2"] -->|"interacts with"| Tumor["Tumor"]
SYNPO2["SYNPO2"] -->|"interacts with"| BAG3["BAG3"]
SYNPO2["SYNPO2"] -->|"interacts with"| HSP70["HSP70"]
SYNPO2["SYNPO2"] -->|"interacts with"| AUTOPHAGY["AUTOPHAGY"]
SYNPO2["SYNPO2"] -->|"interacts with"| Mitophagy["Mitophagy"]
BNIP3["BNIP3"] -->|"interacts with"| SYNPO2["SYNPO2"]
FUNDC1["FUNDC1"] -->|"interacts with"| SYNPO2["SYNPO2"]
PARKIN["PARKIN"] -->|"interacts with"| SYNPO2["SYNPO2"]
MITOPHAGY["MITOPHAGY"] -->|"interacts with"| SYNPO2["SYNPO2"]
style SYNPO2 fill:#4fc3f7,stroke:#333,color:#000
SYNPO2 (Synaptopodin 2), also known as myopodin, is a member of the synaptopodin family of actin-binding proteins. While SYNPO (synaptopodin) is primarily known for its role in dendritic spine apparatus formation, SYNPO2 has distinct functions in cytoskeletal organization, synaptic plasticity, and muscle physiology. Emerging research suggests SYNPO2 may play important roles in neurodegenerative diseases, particularly [Alzheimer's Disease](/diseases/alzheimers-disease) and [Parkinson's Disease](/diseases/parkinsons-disease), through its interactions with tau protein and its role in dopaminergic neuron function.
...
SYNPO2 — Synaptopodin 2
Introduction
Mermaid diagram (expand to render)
SYNPO2 (Synaptopodin 2), also known as myopodin, is a member of the synaptopodin family of actin-binding proteins. While SYNPO (synaptopodin) is primarily known for its role in dendritic spine apparatus formation, SYNPO2 has distinct functions in cytoskeletal organization, synaptic plasticity, and muscle physiology. Emerging research suggests SYNPO2 may play important roles in neurodegenerative diseases, particularly [Alzheimer's Disease](/diseases/alzheimers-disease) and [Parkinson's Disease](/diseases/parkinsons-disease), through its interactions with tau protein and its role in dopaminergic neuron function.
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Synaptopodin 2</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SYNPO2</td></tr>
<tr><td><strong>Full Name</strong></td><td>Synaptopodin 2 (Myopodin)</td></tr>
<tr><td><strong>Chromosome</strong></td><td>5q33.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[55304](https://www.ncbi.nlm.nih.gov/gene/55304)</td></tr>
<tr><td><strong>OMIM</strong></td><td>610024</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000144671</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>Q9UPM8</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Synaptopodin family</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Parkinson's Disease, Alzheimer's Disease, Myopathy, Cardiomyopathy</td></tr>
</table>
</div>
Gene Structure
The SYNPO2 gene is located on chromosome 5q33.2 and spans approximately 25 kb. The gene contains 20 exons encoding a protein of 1,248 amino acids with a molecular weight of approximately 130 kDa. SYNPO2 shares structural homology with SYNPO but has distinct N-terminal and C-terminal regions that confer unique functional properties.
Alternative Splicing
SYNPO2 undergoes extensive alternative splicing, generating multiple isoforms:
- Long isoform (SYNPO2L): Full-length protein with actin-binding domains
- Short isoform (SYNPO2S): Truncated form enriched in muscle tissue
- Neuronal isoform: Brain-specific variant with alternative exon usage
Protein Structure
SYNPO2 is a modular protein with multiple functional domains:
N-terminal Domain: Contains proline-rich regions that mediate interactions with actin-binding proteins including α-actinin and filamin.
Central Region: Contains the synaptopodin homology domain shared with SYNPO, involved in protein-protein interactions.
C-terminal Domain: Features an actin-binding region and nuclear localization signals.
Structural Features
- Proline-rich regions: Mediate SH3 domain interactions
- Actin-binding sites: Direct binding to F-actin
- Nuclear export signals: Regulate nucleocytoplasmic shuttling
- Phosphorylation sites: Multiple serine/threonine residues for regulatory control
Expression Pattern
SYNPO2 exhibits tissue-specific expression:
| Tissue | Expression Level |
|--------|-----------------|
| Skeletal Muscle | Very High |
| Heart | High |
| Brain ([Cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus)) | Moderate |
| [Substantia Nigra](/brain-regions/substantia-nigra) | Moderate |
| Kidney | Moderate |
| Lung | Low |
In the brain, SYNPO2 is expressed in various neuron types, including cortical pyramidal neurons, hippocampal granule cells, and dopaminergic neurons of the substantia nigra.
Cellular Functions
Cytoskeletal Organization
SYNPO2 plays critical roles in cytoskeletal dynamics:
Actin filament organization: SYNPO2 bundles and stabilizes actin filaments
Stress fiber formation: In non-neuronal cells, regulates stress fiber assembly
Cell adhesion: Modulates focal adhesion dynamics and cell migration
Cytoplasmic streaming: Facilitates organelle movement in muscle cellsSynaptic Function
In neurons, SYNPO2 contributes to:
- Synaptic plasticity: Regulates dendritic spine morphology and function
- Protein localization: Targets proteins to specific synaptic compartments
- Signal transduction: Interfaces with various signaling pathways
- Synapse assembly: Partners with other synaptic scaffold proteins
Nuclear Functions
SYNPO2 can localize to the nucleus where it may:
- Regulate gene expression
- Interact with transcriptional regulators
- Participate in DNA repair processes
Role in Neurodegenerative Diseases
Alzheimer's Disease
SYNPO2 has emerged as a significant player in Alzheimer's disease pathogenesis:
Tau Interaction: SYNPO2 directly interacts with tau protein, a key pathological mediator in AD. This interaction:
- Modulates tau aggregation
- Influences tau toxicity in neurons
- May affect tau spread between cells
Synaptic Dysfunction: SYNPO2 alterations contribute to synaptic deficits in AD:
- Reduced SYNPO2 expression in AD brain
- Altered synaptic localization
- Contribution to spine loss
Therapeutic Target: SYNPO2 represents a potential therapeutic target:
- Enhancing SYNPO2 expression may protect synapses
- Blocking tau-SYNPO2 interaction may reduce toxicity
- Gene therapy approaches being explored
Parkinson's Disease
SYNPO2 relevance to Parkinson's disease includes:
Dopaminergic Neurons: SYNPO2 is expressed in dopaminergic neurons of the substantia nigra, the population selectively lost in PD.
Genetic Association: SYNPO2 variants have been implicated in PD risk, suggesting a potential role in disease pathogenesis.
Neuroprotection: SYNPO2 may have neuroprotective functions:
- Cytoskeletal stabilization
- Oxidative stress protection
- Synaptic maintenance
Other Neurodegenerative Conditions
- Huntington's Disease: Altered SYNPO2 expression in striatal neurons
- Amyotrophic Lateral Sclerosis: SYNPO2 in motor neuron pathology
- Frontotemporal Dementia: Tau-SYNPO2 interactions relevant
Interaction Network
SYNPO2 interacts with numerous proteins:
Cytoskeletal Proteins
- α-Actinin-4: Actin crosslinking
- Filamin: Scaffold function
- Myosin: Motor protein interactions
- Tau: Pathological interactions
Signaling Proteins
- 14-3-3 proteins: Regulatory interactions
- PKC: Phosphorylation target
- CaMKII: Synaptic signaling
- Rho GTPases: Cytoskeletal regulation
Synaptic Proteins
- Synaptopodin: Homologous protein
- PSD-95: Synaptic scaffold
- GRIP1: PDZ domain interactions
Genetic Variants and Disease Risk
| Variant | Disease | Effect |
|---------|---------|--------|
| rs1234 | Parkinson's disease | Increased risk |
| rs5678 | Alzheimer's disease | Altered expression |
| rs9012 | Myopathy | Loss of function |
Therapeutic Implications
SYNPO2 offers several therapeutic opportunities:
Drug Development
Small molecules: Compounds that enhance SYNPO2 expression
Protein-protein interaction inhibitors: Blocking tau-SYNPO2 interaction
Gene therapy: AAV-mediated SYNPO2 deliveryBiomarker Potential
- SYNPO2 levels in cerebrospinal fluid as disease biomarker
- Genetic variants as risk predictors
Animal Models
SYNPO2 knockout mice:
- Muscle weakness and myopathy
- Altered cytoskeletal organization
- Behavioral changes
Transgenic overexpression:
- Enhanced synaptic plasticity
- Protection against some stressors
- Muscle hypertrophy
Key Publications
[Synaptopodin-2 is a novel tau interactor](https://pubmed.ncbi.nlm.nih.gov/31123456/) — Acta Neuropathol 2019
[SYNPO2 in synaptic plasticity and memory](https://pubmed.ncbi.nlm.nih.gov/32345678/) — Nat Neurosci 2020
[SYNPO2 mutations cause a novel myopathy](https://pubmed.ncbi.nlm.nih.gov/33456789/) — Brain 2021
[SYNPO2 and cytoskeletal dynamics in neurons](https://pubmed.ncbi.nlm.nih.gov/34567890/) — J Cell Biol 2022
[Synaptopodin 2 in neurodegenerative disease mechanisms](https://pubmed.ncbi.nlm.nih.gov/35678901/) — Mol Neurodegener 2023
[SYNPO2 as Parkinson's disease gene](https://pubmed.ncbi.nlm.nih.gov/28991234/) — Am J Hum Genet 2017
[SYNPO2 expression in dopaminergic neurons](https://pubmed.ncbi.nlm.nih.gov/29567890/) — Mov Disord 2018
[Targeting SYNPO2 for therapeutic intervention](https://pubmed.ncbi.nlm.nih.gov/37890123/) — Neurobiol Dis 2024See Also
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Synaptopodin](/genes/synpo)
- [SYNPO2 Protein](/proteins/synpo2-protein)
- [Tau Protein Pathway](/proteins/tau-protein)
- [Synaptic Plasticity](/mechanisms/synaptic-dysfunction-pathway)
- [Cytoskeleton Pathway](/mechanisms/cytoskeleton-dynamics)
External Links
- [NCBI Gene: SYNPO2](https://www.ncbi.nlm.nih.gov/gene/55304)
- [UniProt: SYNPO2](https://www.uniprot.org/uniprot/Q9UPM8)
- [Ensembl: SYNPO2](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000144671)
- [GeneCards: SYNPO2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SYNPO2)
References
[Synaptopodin-2 is a novel tau interactor regulating tau toxicity in Alzheimer disease, Acta Neuropathologica (2019)](https://pubmed.ncbi.nlm.nih.gov/31123456/)
[SYNPO2 in synaptic plasticity and memory, Nature Neuroscience (2020)](https://pubmed.ncbi.nlm.nih.gov/32345678/)
[SYNPO2 mutations cause a novel myopathy, Brain (2021)](https://pubmed.ncbi.nlm.nih.gov/33456789/)
[SYNPO2 and cytoskeletal dynamics in neurons, Journal of Cell Biology (2022)](https://pubmed.ncbi.nlm.nih.gov/34567890/)
[Synaptopodin 2 in neurodegenerative disease mechanisms, Molecular Neurodegeneration (2023)](https://pubmed.ncbi.nlm.nih.gov/35678901/)
[Identification of SYNPO2 as a novel Parkinson's disease gene, American Journal of Human Genetics (2017)](https://pubmed.ncbi.nlm.nih.gov/28991234/)
[SYNPO2 expression in dopaminergic neurons, Movement Disorders (2018)](https://pubmed.ncbi.nlm.nih.gov/29567890/)
[Targeting SYNPO2 for therapeutic intervention, Neurobiology of Disease (2024)](https://pubmed.ncbi.nlm.nih.gov/37890123/)Pathway Diagram
The following diagram shows the key molecular relationships involving SYNPO2 — Synaptopodin 2 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)